Product NDC: | 68382-132 |
Proprietary Name: | Tamsulosin Hydrochloride |
Non Proprietary Name: | Tamsulosin Hydrochloride |
Active Ingredient(s): | .4 mg/1 & nbsp; Tamsulosin Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68382-132 |
Labeler Name: | Zydus Pharmaceuticals (USA) Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078225 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100427 |
Package NDC: | 68382-132-10 |
Package Description: | 1000 CAPSULE in 1 BOTTLE (68382-132-10) |
NDC Code | 68382-132-10 |
Proprietary Name | Tamsulosin Hydrochloride |
Package Description | 1000 CAPSULE in 1 BOTTLE (68382-132-10) |
Product NDC | 68382-132 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Tamsulosin Hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20100427 |
Marketing Category Name | ANDA |
Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
Substance Name | TAMSULOSIN HYDROCHLORIDE |
Strength Number | .4 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |